Skip to main content

Table 1 Baseline clinical and electrocardiographic characteristics of the study population

From: Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy

 

N = 40

Men/Women

31/9

Age

60.2 ± 10.4

Body surface area (g/m2)

1.74 ± 0.17

Family history of HCM

1(2.5%)

Family history of SCD

3 (7.5%)

History of syncope

3 (7.5%)

NYHA functional class I/II

25 (63.5%)/15 (37.5%)

Hypertension

17 (42.5%)

Diabetes mellitus

4 (10%)

Smoker

3 (7.5%)

Medications

 

 Calcium-channel blockers

13 (32.5%)

 Beta blockers

9 (22.5%)

 ACEi/ARB

10 (25%)

 Aspirin

10 (25%)

 Diuretics

6 (15%)

SBP/DBP

125.9 ± 13.7/75.9 ± 8.7

Electrocardiogram

 

  T wave inversion

39 (97.5%)

  Giant T waves ≥10mm

12 (30%)

  1. HCM denotes hypertrophic cardiomyopathy; SCD, sudden cardiac death; NYHA, New York Heart Association; ACEi/ARB, angiotension converting esterase inhibitor/angiotensin receptor blocker; S(D)BP, systolic (diastolic) blood pressure; ECG, electrocardiogram.